News | Congenital Heart | June 12, 2015

Fusion Ultrasound/Angiography Imaging May Improve Congenital Heart Disease Surgical Guidance

June 12, 2015 - Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

While FFEI systems have been used in adult patients undergoing various cardiac procedures, its use has not been widely explored during catheterization procedures in pediatric patients.  In this study, the FFEI system was successfully used in 25 patients with congenital heart disease from January 2013 to January 2015. Twenty out of 25 procedures were graded as superior (80%) and none were graded as inferior. "These results show that procedural guidance using FFEI systems in congenital heart disease is not only feasible, but it also provides improved guidance over the current standard of care," noted Primary Investigator Pei-Ni Jone, M.D., of Children's Hospital Colorado. 

"Future studies might explore whether the FFEI system could decrease exposure to radiation with decreased use of fluoroscopy, which would be an important additional benefit in such a young population," Jone concluded.
 
Researchers on the study, "Procedural Guidance Using a Fused Fluoroscopic/Three Dimensional Echocardiography Imaging System in Congenital Heart Disease," include Pei-Ni Jone, Michael DiMaria, and Thomas Fagan from the University of Colorado School of Medicine in Aurora, Colo.; and John Bracken of Philips Research North America in Briarcliff Manor, N.Y.
 
Jone will present a poster based on this research Monday, June 15, 2015, during ASE at the Hynes Convention Center in Boston, Mass. 
 
For more information: www.asescientificsessions.org
 

Related Content

BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies| September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
News | Vena Cava Filters| September 26, 2017
September 26, 2017 — The one-year results of the SENTRY...
Treatment of Heart Attack Patients Depends on Cancer History
News | Cardio-oncology| September 26, 2017
Treatment of heart attack patients depends on their history of cancer, according to research published recently in...
CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure| September 25, 2017
BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial was presented during...
Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging| September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Overlay Init